- Home
- EVR vs RGC Comparison
EVR vs RGC Comparison
Compare EVR & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVR | RGC |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 11.5B |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EVR | RGC |
|---|---|---|
| Price | $267.32 | $23.00 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $345.67 | N/A |
| AVG Volume (30 Days) | ★ 627.6K | 104.8K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | ★ 54.74 | N/A |
| EPS | ★ 14.05 | N/A |
| Revenue | ★ $3,880,084,000.00 | N/A |
| Revenue This Year | $22.35 | N/A |
| Revenue Next Year | $13.37 | N/A |
| P/E Ratio | $18.97 | ★ N/A |
| Revenue Growth | ★ 29.49 | N/A |
| 52 Week Low | $148.63 | $9.39 |
| 52 Week High | $388.71 | $950.00 |
Technical Indicators
Market Signals| Indicator | EVR | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 28.65 | 41.77 |
| Support Level | $238.96 | $20.81 |
| Resistance Level | $320.26 | $26.42 |
| Average True Range (ATR) | 13.18 | 2.17 |
| MACD | -3.41 | -0.31 |
| Stochastic Oscillator | 3.19 | 19.38 |
Price Performance
Historical ComparisonAbout EVR Evercore Inc.
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.